Quick Links

 Clinical Collaborations

City of Hope employs a multidisciplinary approach to cancer treatment, enlisting the expertise of various specialists to address the individual needs of each patient.

Here, treatment teams are composed of caregivers who work in concert to address all aspects of patient care, from oncologists, surgeons and nurses to social workers, psychiatrists, nutritionists and spiritual care providers. Clinicians and scientists also join forces to rapidly and efficiently transform laboratory discoveries into novel, targeted therapies.

Our collaborative pursuits extend beyond City of Hope as well. We frequently conduct clinical trials in partnership with government agencies and other academic centers, ensuring that patients here and elsewhere receive the potential benefit of promising investigative therapies as quickly as possible.

 Press Releases

1/17/2012 - Smita Bhatia, physician and researcher at City of Hope, elected to American Society for Clinical Oncology board of directors

Smita Bhatia, M.D., M.P.H., the Ruth Ziegler Chair in Population Sciences at City of Hope, has been elected to serve on the board of directors of the American Society for Clinical Oncology (ASCO). Her four-year term will begin during ASCO’s annual meeting at Chicago in early June.

11/28/2011 - Childhood cancer survivors with specific genes are at higher risk of developing heart problems after treatment with anthracycline chemotherapy

The study, published in the Journal of Clinical Oncology, found that a specific variation of the CBR3 gene is linked to the development of cardiovascular complications. Investigators are conducting further research to develop tests and treatment guidelines that may reduce or mitigate this risk.

11/23/2011 - Brain imaging, behavior research reveals physicians learn more by paying attention to failure

When seeking a physician, you should look for one with experience. Right? Maybe not. Research on physicians' decision-making processes has revealed that those who pay attention to failures as well as successes become more adept at selecting the correct treatment.

11/15/2011 - City of Hope researchers discover genetic markers that put lymphoma survivors at higher risk for secondary leukemia

A team of City of Hope researchers has discovered genetic markers that help identify which patients might be at risk, and are closer to understanding how physicians may prevent certain patients from developing this deadly secondary cancer. The study was published in the Nov. 15 edition of the journal Cancer Cell.

11/10/2011 - Children’s Hospital Los Angeles and City of Hope Researchers Receive NCI Program Project Grant to Investigate Neuroblastoma Tumor Microenvironment

A $2.5 million grant from the National Cancer Institute (NCI)’s Tumor Microenvironment Network will enable cancer researchers from City of Hope and Children’s Hospital Los Angeles to investigate drug resistance in neuroblastoma.

 Search

Go!
Advanced Search Options
News & Publications Search

 ThinkCure

ThinkCureThinkCure Weekend is here! Centered at Dodger Stadium, ThinkCure Weekend includes all of Los Angeles through the Web, TV and radio. It brings L.A. together to share stories of inspiration and to fight cancer by raising money that funds innovative research at City of Hope and Childrens Hospital Los Angeles.
Learn more >>

NCI CCC LogoCity of Hope is one of 40 Comprehensive Cancer Centers, the highest designation bestowed by the National Cancer Institute and a recognition of excellence in cancer treatment, research, prevention and education.
City of Hope strongly supports and values the uniqueness of all individuals and promotes a work environment where diversity is embraced.
NCI CCC LogoThe National Comprehensive Cancer Network®
(NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer.
Best Of logoWe subscribe to the HON code of the Healthcare on the Net Foundation.